AZ buys Ionis’ NASH candidate
admin 10th April 2018 Uncategorised 0AstraZeneca has bought rights to an experimental antisense therapy from Ionis Pharmaceuticals, in a deal that could be worth more than $300 million
More: AZ buys Ionis’ NASH candidate
Source: News